776290

Novo Nordisk Inc. — FEI 2244771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plainsboro, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)